AT375367B - Verfahren zur herstellung von als histamin h2-rezeptor-antagonisten wirkenden nitroverbindungen - Google Patents

Verfahren zur herstellung von als histamin h2-rezeptor-antagonisten wirkenden nitroverbindungen

Info

Publication number
AT375367B
AT375367B AT0395179A AT395179A AT375367B AT 375367 B AT375367 B AT 375367B AT 0395179 A AT0395179 A AT 0395179A AT 395179 A AT395179 A AT 395179A AT 375367 B AT375367 B AT 375367B
Authority
AT
Austria
Prior art keywords
histamine
receptor antagonists
nitro compounds
compounds acting
producing nitro
Prior art date
Application number
AT0395179A
Other languages
English (en)
Other versions
ATA395179A (de
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ATA395179A publication Critical patent/ATA395179A/de
Application granted granted Critical
Publication of AT375367B publication Critical patent/AT375367B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/12—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
AT0395179A 1978-05-30 1979-05-30 Verfahren zur herstellung von als histamin h2-rezeptor-antagonisten wirkenden nitroverbindungen AT375367B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2411678 1978-05-30

Publications (2)

Publication Number Publication Date
ATA395179A ATA395179A (de) 1983-12-15
AT375367B true AT375367B (de) 1984-07-25

Family

ID=10206649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0395179A AT375367B (de) 1978-05-30 1979-05-30 Verfahren zur herstellung von als histamin h2-rezeptor-antagonisten wirkenden nitroverbindungen

Country Status (25)

Country Link
US (2) US4238493A (de)
EP (1) EP0005984B1 (de)
JP (1) JPS54157584A (de)
AR (1) AR222999A1 (de)
AT (1) AT375367B (de)
AU (1) AU522259B2 (de)
BG (1) BG31649A3 (de)
CA (1) CA1118774A (de)
CS (1) CS228116B2 (de)
DD (1) DD144057A5 (de)
DE (1) DE2965716D1 (de)
DK (1) DK223979A (de)
ES (1) ES481076A1 (de)
FI (1) FI791737A (de)
GR (1) GR68500B (de)
HU (1) HU181960B (de)
IE (1) IE48510B1 (de)
IL (1) IL57416A (de)
NO (1) NO151322C (de)
PL (1) PL117921B1 (de)
PT (1) PT69686A (de)
RO (1) RO78154A (de)
SU (1) SU888815A3 (de)
YU (1) YU127179A (de)
ZA (1) ZA792608B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
US4405624A (en) * 1978-05-30 1983-09-20 Smith Kline & French Laboratories Limited Nitro-substituted dihydropyrroles and tetrahydropyridines, compositions, compounds, and medicinal use
IL61234A (en) * 1979-10-24 1984-03-30 Smith Kline French Lab Guanidino thiazolyl alkylamino(alkylthioalkylamino)nitrotetrahydropyridines,process for preparing them and pharmaceutical compositions containing them
PT72320B (en) * 1980-01-08 1982-07-23 Glaxo Group Ltd Process for preparation of a furan derivative
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4439437A (en) * 1981-04-28 1984-03-27 Smith Kline & French Laboratories Limited 2-[2-Thiazolyl or 2-guanidino-4-thiazolyl methylthioethyl(or butyl)amino]-3-(hydroxy or carboxy)pyridines, compositions containing same and method of use
IE53068B1 (en) * 1981-06-15 1988-05-25 Merck & Co Inc Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them
US4525477A (en) * 1981-12-02 1985-06-25 Smith Kline & French Laboratories Limited 2-Thiazolyl, isothiazolyl, oxazolyl and isoxazolyl alkylamino-3-nitro-heterocyclic compounds
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
GR82004B (de) * 1983-06-30 1984-12-12 American Home Prod
IN170284B (de) * 1988-10-26 1992-03-07 Takeda Chemical Industries Ltd
EP0375613A3 (de) * 1988-12-21 1990-11-28 Ciba-Geigy Ag Nitroenamine
US6133291A (en) * 1998-10-16 2000-10-17 Schering Corporation N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1223686A (en) 1967-02-24 1971-03-03 Ici Ltd Salts of pyrimidine derivatives and the use thereof as fungicides
US3980781A (en) * 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
DE1617705C3 (de) * 1966-12-19 1973-10-11 Oreal Kosmetisches Mittel fur die Haar behandlung
US3518251A (en) * 1967-06-07 1970-06-30 Geigy Ag J R Certain aminoalkylamino substituted azacycloalkenes
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
US3920822A (en) * 1972-09-05 1975-11-18 Smith Kline French Lab Inhibition of histamine activity with cyanoguanidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4005205A (en) * 1974-04-24 1977-01-25 Smith Kline & French Laboratories Limited Compositions and methods for inhibiting H2 histamine receptors
CH595061A5 (de) * 1974-05-10 1978-01-31 Ciba Geigy Ag
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1563090A (en) * 1975-07-31 1980-03-19 Smith Kline French Lab Cyclobutene-diones
IN146736B (de) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
DE2752820A1 (de) * 1977-11-26 1979-05-31 Bayer Ag Neue nitrosubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4297498A (en) * 1978-01-30 1981-10-27 Mead Johnson & Company 4-Tertiary-amino-2,6-diaminopyridine 1-oxides
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them

Also Published As

Publication number Publication date
AR222999A1 (es) 1981-07-15
ZA792608B (en) 1980-06-25
PL117921B1 (en) 1981-09-30
DK223979A (da) 1979-12-01
HU181960B (en) 1983-11-28
NO151322C (no) 1985-03-20
PT69686A (en) 1979-06-01
CS228116B2 (en) 1984-05-14
IL57416A0 (en) 1979-09-30
FI791737A (fi) 1979-12-01
IE48510B1 (en) 1985-02-20
YU127179A (en) 1983-01-21
PL215970A1 (de) 1980-02-11
US4238493A (en) 1980-12-09
ATA395179A (de) 1983-12-15
EP0005984B1 (de) 1983-06-22
SU888815A3 (ru) 1981-12-07
RO78154A (ro) 1982-02-01
JPS54157584A (en) 1979-12-12
BG31649A3 (en) 1982-02-15
DE2965716D1 (en) 1983-07-28
ES481076A1 (es) 1980-02-01
DD144057A5 (de) 1980-09-24
CA1118774A (en) 1982-02-23
AU522259B2 (en) 1982-05-27
EP0005984A1 (de) 1979-12-12
US4656176A (en) 1987-04-07
AU4758079A (en) 1979-12-06
GR68500B (de) 1982-01-07
NO151322B (no) 1984-12-10
NO791763L (no) 1979-12-03
IL57416A (en) 1983-03-31
IE791099L (en) 1979-11-30

Similar Documents

Publication Publication Date Title
AT375367B (de) Verfahren zur herstellung von als histamin h2-rezeptor-antagonisten wirkenden nitroverbindungen
AT363922B (de) Verfahren zur herstellung von neuen aminderivaten von glyzerinaethern
AT366671B (de) Verfahren zur herstellung von neuen imidazolidinen
ATA373379A (de) Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen
AT363076B (de) Verfahren zur herstellung neuer imidazolverbindungen
AT374474B (de) Verfahren zur herstellung von neuen piperidinverbindungen
LU77703A1 (de) Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
AT369783B (de) Verfahren zur herstellung von neuen ergot-alkaloiden
DK298180A (da) Histamin h2-antagonister
AT366699B (de) Verfahren zur herstellung von 3'', 4''-diacyltylosinderivaten
AT380240B (de) Verfahren zur herstellung von neuen heterocyclischen verbindungen
AT375927B (de) Verfahren zur herstellung von neuen imidazolderivaten
AT368497B (de) Verfahren zur herstellung von imidazolinen
ATA353178A (de) Verfahren zur herstellung von neuen azacyclyl- -verbindungen
AT375368B (de) Verfahren zur herstellung von als histamin h2rezeptor-antagonisten wirkenden 3-nitropyrrolderivaten
AT350735B (de) Verfahren zur herstellung von neuen ribo- furanosyl-imidazolderivaten
DK531483D0 (da) Fremgangsmade til fremstilling af histamin h2-antagonister
AT358198B (de) Verfahren zur herstellung von neuen pyrimidin- -derivaten
AT372954B (de) Verfahren zur herstellung von neuen spirobenzofuranonverbindungen
AT367047B (de) Verfahren zur herstellung von gegebenenfalls substituierten 2-mercapto-4,6-di-chlor-s-triazinen
AT366035B (de) Verfahren zur herstellung von neuen 5-substituier-ten hydantoinen
ATA716179A (de) Verfahren zur herstellung von neuen substi- tuierten 1-(3-aminosulfonylphenyl)-2- alkyl- aminoaethanolen
ATA790079A (de) Verfahren zur herstellung von neuen 5-substituierten benzo(c)-chinolinen
AT359189B (de) Verfahren zur herstellung von neuen cephalos- porinverbindungen
ATA710079A (de) Verfahren zur herstellung von neuen cephalos- porinverbindungen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee